- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05315193
Effect of Exercise Training in Coronary Artery Disease Patients After Stenting
Effects of Exercise Training on Ankle-brachial Index and Quality of Life in Coronary Artery Disease Patients After Stenting.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mehwish Waseem, MSPT(CPPT)
- Phone Number: 0331-5309015
- Email: mehwish.waseem@riphah.edu.pk
Study Contact Backup
- Name: Umair Ahmad, MSPT(CPPT)
- Phone Number: 0315-9534776
- Email: umair00082@gmail.com
Study Locations
-
-
KPK
-
Peshawar, KPK, Pakistan, 25000
- Peshawar Institute of Cardiology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- GCS = 15
- Disease chronicity: 1-3 years Elective / stenting procedure
- Single or Double vessel stunting EF: 35 above
Exclusion Criteria:
- Unwilling to participate in research
- Known cases of Uncontrolled DM or HTN
- Known cases of Cognitive/memory/neurological disorders
- Known cases of any Systemic disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Structured In-patient and Home plan
|
A patient education session and a protocol comprise of 3 days.
It consists of three different levels having progressive activities.
The in-patient protocol will start from the day of the procedure.
Each level contains 2 to 6 tasks, performed in sets of 5-10 repetitions 3 times a day.
Home plan: Walking 3 days a week starting from normal pace ((RPE: 8-9) for10 minutes and progressively increased intensity and duration over the period of 12 weeks (RPE: 13-14).
|
Placebo Comparator: Conventional therapy
Conventional protocol as per guidelines
|
In-Patient: Wound care, Bed mobility: AROMS (10 Reps*3sets*TD), Breathing Exercise (10 Reps*3sets*TD), Mobilization (Walk as per patient tolerance) Patient Education: To keep the heart healthy Diet Avoid strenuous exercise and lifting heavy objects Avoid valsalva manure, Quit smoking Lower cholesterol levels, Maintain a healthy weight Control other conditions, such as diabetes and high blood pressure Take medications as prescribed by your doctor Get regular exercise: Walking at a normal pace as per tolerance (RPE up to 10) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ankle-brachial index
Time Frame: 12 weeks
|
Changes From the Baseline,6th week and 12 weeks, measured through the ratio of the systolic blood pressure (SBP) measured at the ankle to that measured at the brachial artery to detect Peripheral Artery Disease.
Normal Ankle-brachial index ranges from 1.0 to 1.4.
|
12 weeks
|
Quality of life index cardiac version -IV
Time Frame: 12 weeks
|
Changes From the Baseline, 6th week and 12 weeks measured through Quality of life index cardiac version -IV.
It consists of 70 items.
Each item used a six-point Likert rating scale.
Scores calculated for overall quality of life in four domains: health and functioning (15 items), social and economic (8 items), psychological/spiritual (7 items), and family (5 items).
High scores indicated a better quality of life.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dyspnea
Time Frame: 3-5 days
|
Changes From the Baseline, measured through Rose Dyspnea Scale.
The scale consists of four items, with scores ranging from 0 to 4, where 0 indicates no dyspnea with activity, and increasing scores indicate greater limitations because of dyspnea.
|
3-5 days
|
Rate of perceived exertion (RPE)
Time Frame: 12 weeks
|
Changes From the Baseline,6th week and 12 weeks, measured through Borg RPE scale which measures a person's perception of their effort and exertion breathlessness, and fatigue during physical work rating between 6 and 20.
The higher the number, the more intense the exercise.
An RPE of 6 is often referred to as just above rest, hardly any exertion, while an RPE of 20 is a maximal effort.
|
12 weeks
|
Forced Expiratory Volume in 1 second (FEV1)
Time Frame: 12 weeks
|
Changes from the Baseline,6th week and 12 weeks, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters
|
12 weeks
|
Forced vital Capacity (FVC)
Time Frame: 12 weeks
|
Changes From the Baseline,6th week and 12 weeks, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mehwish Waseem, MSPT(CPPT), Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rec/01279 Umair Ahmad
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Structured In-patient and Home plan
-
Riphah International UniversityCompletedCoronary Artery Disease | Stent RestenosisPakistan
-
University of TennesseeWithdrawnOccupational/Physical Therapy | Post-operative Breast ReconstructionUnited States
-
University Hospital of FerraraUniversità degli Studi di FerraraRecruitingChronic Kidney Disease Stage 5 on DialysisItaly
-
Oslo University HospitalVirginia Commonwealth University; Sunnaas Rehabilitation HospitalCompletedTraumatic Brain InjuryNorway
-
Boston UniversityOhio State University; Centers for Disease Control and Prevention; US Department...Recruiting
-
Michael Garron HospitalUniversity of Toronto; Ontario Ministry of Health and Long Term Care; Southlake...CompletedChronic Obstructive Pulmonary Disease | Multiple ComorbidityCanada
-
Texas Christian UniversityRecruitingSubstance Use | Opioid UseUnited States
-
Mayo ClinicMinnesota Department of Human Services; Elder NetworkCompleted
-
Norwegian University of Science and TechnologyStiftelsen Helse og RehabiliteringCompletedCoronary Artery DiseaseNorway
-
Göteborg UniversityCompletedDiabetes Mellitus, Type 1